Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28
Published October 15, 2025 · Recall initiated: September 2, 2025
Summary
FDA records drug Class II recall D-0007-2026, published October 15, 2025 and initiated September 2, 2025. Recalling firm: AvKARE; Status: Ongoing; Reported quantity: 2192 cartons; Lot: Lot # LF41138A; Exp 06/30/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Content Uniformity Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if NORGESTIMATE AND ETHINYL ESTRADIOL has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NORGESTIMATE AND ETHINYL ESTRADIOL
- Manufacturer
- AvKARE
- Distributor
- U.S. Nationwide
- Lot
- Lot # LF41138A; Exp 06/30/2027
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for AccordOctober 15, 2025
- FDASuccinylcholine Chloride Injection, USP, 200 mg/10 mL (20 mg/mL), 25 x 10 mL Multiple-Dose Vials, ForOctober 15, 2025
- FDAAFCO, Hand Sanitizer (Isopropyl Alcohol-Based, Product 5515), Manufactured by: AFCO, 550 Development Avenue,October 15, 2025
- FDAMajor ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 50 Tablets (5x10) blister package, Rx Only, PackagedOctober 15, 2025
- FDAWyandotte, Sanifect E3, Hand Sanitizer (Ethanol-Based, Product 5511), Ethyl Alcohol 60.1%, Manufacture By:October 15, 2025
- FDAMajor ChlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100 Tablets (10x10) blister package, Rx Only, PackagedOctober 15, 2025
Questions about this recall
Was Norgestimate and Ethinyl Estradiol Tablets, USP, 0.18 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.25 mg/0.025 mg, 3 Units, 3x28 tablets blister cards per carton, Rx only, Manufactured for AvKARE, Pulaski, TN 38478. Carton NDC: 42291-565-84; Blister NDC: 42291-565-28 recalled?
Yes. FDA published recall D-0007-2026 on October 15, 2025. Reported hazard: Failed Content Uniformity Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NORGESTIMATE AND ETHINYL ESTRADIOL.